Table 1.
Participant demographics.
Parkinson’s disease | HC | |
---|---|---|
n | 39 | 20 |
Age (years) | 68.7 (8.0) | 71.4 (8.1) |
Sex (M/F) | 26/13 | 7/13 |
Disease duration (years) | 7.1 (5.7) | |
MDS-UPDRS III | 40.1 (13.6) | |
PIGD | 5.5 (3.5) | |
Hoehn and Yahr | 2.4 (0.6) | |
MoCA | 24.4 (4.1) | 27.1 (1.9) |
Levodopa equivalent dose (mg) | 1,024 (75–8,680) |